摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-甲基-6,7-二氢-5H-环戊二烯并[c]吡啶 | 121259-09-4

中文名称
1-甲基-6,7-二氢-5H-环戊二烯并[c]吡啶
中文别名
——
英文名称
2-methyl-3,4-cyclopentenopyridine
英文别名
1-methyl-6,7-dihydro-5H-cyclopenta[c]pyridine
1-甲基-6,7-二氢-5H-环戊二烯并[c]吡啶化学式
CAS
121259-09-4
化学式
C9H11N
mdl
——
分子量
133.193
InChiKey
SKLYVKCOZSNNMU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:3a365b8365fee7af443e11d6c20bf0b7
查看

反应信息

  • 作为反应物:
    描述:
    1-甲基-6,7-二氢-5H-环戊二烯并[c]吡啶1-苯并三唑-1-基-3-氯丙烷-2-酮N,N-二甲基甲酰胺 为溶剂, 反应 0.67h, 以32%的产率得到1-(1H-1,2,3-benzotriazol-1-ylmethyl)-8,9-dihydro-7H-pyrrolo[3,2,1-ij]quinoline
    参考文献:
    名称:
    A New Three-Carbon Synthon for Efficient Synthesis of Benzannelated and 1-(2-Arylethenyl) Heterocycles
    摘要:
    The novel three-carbon synthon 1-(1H-1,2,3-benzotriazol-1-yl)-3-chloroacetone for the synthesis of benzothiazoles, pyrido[1,2-a]indoles, and styryl-substituted indolizines and imidazo[1,2-a]pyridines is reported. The proposed routes are a general and efficient approach for heterocyclizations followed by benzannelations or attachment of arylethenyl pharmacophores.
    DOI:
    10.1021/jo000946r
  • 作为产物:
    参考文献:
    名称:
    Simple method for the synthesis of bicyclic pyridine bases from 1-ethynylcycloalkanols and carboxylic acid chlorides
    摘要:
    DOI:
    10.1007/bf00959893
点击查看最新优质反应信息

文献信息

  • NOVEL MODULATORS OF SPHINGOSINE PHOSPHATE RECEPTORS
    申请人:Roberts Edward
    公开号:US20100010001A1
    公开(公告)日:2010-01-14
    Compounds that activate a sphingosine-1-phosphate receptor of the subtype 1 are provided. Certain compounds selectively activate the receptor subtype 1 in relation to the sphinogosine-4-phosphate receptor subtype 3. Uses and methods of inventive compounds for treatment of malconditions wherein activation, agonism, inhibition or antagonism of the S1P1 is medically indicated are provided.
    提供了激活1型鞘氨醇-1-磷酸受体的化合物。某些化合物在与鞘氨醇-4-磷酸受体亚型3相比,选择性地激活受体亚型1。提供了用于治疗需要医学上激活、激动、抑制或拮抗S1P1的恶性疾病的创新化合物的用途和方法。
  • Pyrimidine derivatives
    申请人:Sato Michitaka
    公开号:US20070197551A1
    公开(公告)日:2007-08-23
    This invention provides pyrimidine derivatives represented by a formula, in the formula, ring A stands for carbocyclic group or heterocyclic group, X 1 stands for hydrogen, lower alkyl, amino, etc., X 2 stands for hydrogen or lower alkyl, Y stands for a direct bond or sulfur or nitrogen, n stands for an integer of 0-4, and Ar stands for a group of the following formula, or a salt thereof, which concurrently exhibit 5-HT 1A agonistic activity and 5-HT 3 antagonistic activity and are useful for therapy and treatments of diseases such as IBS. The invention furthermore provides a therapeutic method of IBS, characterized by having 5-HT 1A agonistic activity and 5-HT 3 antagonistic activity work simultaneously and cooperatively in vivo, which comprises either administering 5-HT 3 antagonistic agent which concurrently exhibits 5-HT 1A agonistic activity, or administering 5-HT 1A agonistic agent and 5-HT 3 antagonistic agent simultaneously, in sequence or at an interval.
    本发明提供了由下式表示的嘧啶衍生物,其中,环A代表碳环基团或杂环基团,X1代表氢、低碳基、氨基等,X2代表氢或低碳基,Y代表直接键或硫或氮,n代表0-4的整数,Ar代表以下式的基团,或其盐,同时表现出5-HT1A激动活性和5-HT3拮抗活性,并且对治疗诸如肠易激综合征等疾病有用。本发明进一步提供了一种IBS治疗方法,其特征在于在体内同时和协同地发挥5-HT1A激动活性和5-HT3拮抗活性,包括给予同时表现出5-HT1A激动活性和5-HT3拮抗活性的5-HT3拮抗剂,或同时给予5-HT1A激动剂和5-HT3拮抗剂,按顺序或间隔给予。
  • TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20150299146A1
    公开(公告)日:2015-10-22
    The compound represented by formula (1): wherein R 4 and R 5 each represents a hydrogen atom, a halogen atom, or a C1-C3 alkyl group; R 6 represents a C1-C4 alkyl group, a C3-C6 cycloalkyl group, or the like; R 7 , R 8 , and R 9 each represents a hydrogen atom, a halogen atom, or the like; R 10 represents a C1-C3 alkyl group, or the like; R 13 represents a C1-C3 alkyl group, or the like; and Q represents a phenyl group, or the like; has an excellent control effect on pests.
    式(1)所代表的化合物:其中,R4和R5分别表示氢原子、卤素原子或C1-C3烷基;R6表示C1-C4烷基、C3-C6环烷基或类似物;R7、R8和R9分别表示氢原子、卤素原子或类似物;R10表示C1-C3烷基或类似物;R13表示C1-C3烷基或类似物;Q表示苯基或类似物。该化合物对害虫有极好的控制效果。
  • TETRAZOLINONE COMPOUND AND USE THEREOF
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:EP2927218A1
    公开(公告)日:2015-10-07
    The compound represented by formula (1): wherein R4 and R5 each represents a hydrogen atom, a halogen atom, or a C1-C3 alkyl group; R6 represents a C1-C4 alkyl group, a C3-C6 cycloalkyl group, or the like; R7, R8, and R9 each represents a hydrogen atom, a halogen atom, or the like; R10 represents a C1-C3 alkyl group, or the like; R13 represents a C1-C3 alkyl group, or the like; and Q represents a phenyl group, or the like; has an excellent control effect on pests.
    式 (1) 所代表的化合物: 其中 R4 和 R5 分别代表氢原子、卤素原子或 C1-C3 烷基;R6 代表 C1-C4 烷基、C3-C6 环烷基或类似基团;R7、R8 和 R9 分别代表氢原子、卤素原子或类似基团;R10 代表 C1-C3 烷基或类似基团;R13 代表 C1-C3 烷基或类似基团;以及 Q 代表苯基或类似基团; 对害虫具有极佳的防治效果。
  • PYRIMIDINE DERIVATIVE
    申请人:ASKA Pharmaceutical Co., Ltd.
    公开号:EP1724267B1
    公开(公告)日:2013-11-06
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-